FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311154294> ?p ?o ?g. }

• W4311154294 endingPage "238" @default.
• W4311154294 startingPage "223" @default.
• W4311154294 abstract "Background: Because adult cardiomyocytes have little regenerative capacity, resident cardiac fibroblasts (CFs) synthesize extracellular matrix after myocardial infarction (MI) to form fibrosis, leading to cardiac dysfunction and heart failure. Therapies that can regenerate the myocardium and reverse fibrosis in chronic MI are lacking. The overexpression of cardiac transcription factors, including Mef2c/Gata4/Tbx5/Hand2 (MGTH), can directly reprogram CFs into induced cardiomyocytes (iCMs) and improve cardiac function under acute MI. However, the ability of in vivo cardiac reprogramming to repair chronic MI with established scars is undetermined. Methods: We generated a novel Tcf21 iCre /reporter/MGTH2A transgenic mouse system in which tamoxifen treatment could induce both MGTH and reporter expression in the resident CFs for cardiac reprogramming and fibroblast lineage tracing. We first tested the efficacy of this transgenic system in vitro and in vivo for acute MI. Next, we analyzed in vivo cardiac reprogramming and fusion events under chronic MI using Tcf21 iCre /Tomato/MGTH2A and Tcf21 iCre /mTmG/MGTH2A mice, respectively. Microarray and single-cell RNA sequencing were performed to determine the mechanism of cardiac repair by in vivo reprogramming. Results: We confirmed the efficacy of transgenic in vitro and in vivo cardiac reprogramming for acute MI. In chronic MI, in vivo cardiac reprogramming converted ≈2% of resident CFs into iCMs, in which a majority of iCMs were generated by means of bona fide cardiac reprogramming rather than by fusion with cardiomyocytes. Cardiac reprogramming significantly improved myocardial contraction and reduced fibrosis in chronic MI. Microarray analyses revealed that the overexpression of MGTH activated cardiac program and concomitantly suppressed fibroblast and inflammatory signatures in chronic MI. Single-cell RNA sequencing demonstrated that resident CFs consisted of 7 subclusters, in which the profibrotic CF population increased under chronic MI. Cardiac reprogramming suppressed fibroblastic gene expression in chronic MI by means of conversion of profibrotic CFs to a quiescent antifibrotic state. MGTH overexpression induced antifibrotic effects partly by suppression of Meox1, a central regulator of fibroblast activation. Conclusions: These results demonstrate that cardiac reprogramming could repair chronic MI by means of myocardial regeneration and reduction of fibrosis. These findings present opportunities for the development of new therapies for chronic MI and heart failure." @default.
• W4311154294 created "2022-12-24" @default.
• W4311154294 creator A5004269034 @default.
• W4311154294 creator A5011276506 @default.
• W4311154294 creator A5014405945 @default.
• W4311154294 creator A5017610862 @default.
• W4311154294 creator A5019276297 @default.
• W4311154294 creator A5019488402 @default.
• W4311154294 creator A5044996527 @default.
• W4311154294 creator A5045649013 @default.
• W4311154294 creator A5048163457 @default.
• W4311154294 creator A5052837574 @default.
• W4311154294 creator A5061811239 @default.
• W4311154294 creator A5067804516 @default.
• W4311154294 creator A5069453818 @default.
• W4311154294 creator A5077262809 @default.
• W4311154294 creator A5083622539 @default.
• W4311154294 creator A5086055038 @default.
• W4311154294 creator A5090216840 @default.
• W4311154294 date "2023-01-17" @default.
• W4311154294 modified "2023-10-09" @default.
• W4311154294 title "Direct Reprogramming Improves Cardiac Function and Reverses Fibrosis in Chronic Myocardial Infarction" @default.
• W4311154294 cites W1972160020 @default.
• W4311154294 cites W2010368308 @default.
• W4311154294 cites W2013657540 @default.
• W4311154294 cites W2015897555 @default.
• W4311154294 cites W2035006418 @default.
• W4311154294 cites W2082714048 @default.
• W4311154294 cites W2104010513 @default.
• W4311154294 cites W2108862261 @default.
• W4311154294 cites W2143298795 @default.
• W4311154294 cites W2156140279 @default.
• W4311154294 cites W2159392834 @default.
• W4311154294 cites W2160092129 @default.
• W4311154294 cites W2165411963 @default.
• W4311154294 cites W2167202160 @default.
• W4311154294 cites W2183587606 @default.
• W4311154294 cites W2463195288 @default.
• W4311154294 cites W2482213414 @default.
• W4311154294 cites W2522665294 @default.
• W4311154294 cites W2766437506 @default.
• W4311154294 cites W2780773606 @default.
• W4311154294 cites W2783252067 @default.
• W4311154294 cites W2794480084 @default.
• W4311154294 cites W2800350399 @default.
• W4311154294 cites W2912671957 @default.
• W4311154294 cites W2918090175 @default.
• W4311154294 cites W2924188812 @default.
• W4311154294 cites W2928665623 @default.
• W4311154294 cites W2949177718 @default.
• W4311154294 cites W2972517993 @default.
• W4311154294 cites W3003299879 @default.
• W4311154294 cites W3009508101 @default.
• W4311154294 cites W3045651959 @default.
• W4311154294 cites W3046768928 @default.
• W4311154294 cites W3047129023 @default.
• W4311154294 cites W3047141442 @default.
• W4311154294 cites W3109793392 @default.
• W4311154294 cites W3113296670 @default.
• W4311154294 cites W3160301984 @default.
• W4311154294 cites W3163348136 @default.
• W4311154294 cites W3165187094 @default.
• W4311154294 cites W3176137376 @default.
• W4311154294 cites W3177093973 @default.
• W4311154294 cites W3183829531 @default.
• W4311154294 cites W4206978229 @default.
• W4311154294 doi "https://doi.org/10.1161/circulationaha.121.058655" @default.
• W4311154294 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36503256" @default.
• W4311154294 hasPublicationYear "2023" @default.
• W4311154294 type Work @default.
• W4311154294 citedByCount "15" @default.
• W4311154294 countsByYear W43111542942023 @default.
• W4311154294 crossrefType "journal-article" @default.
• W4311154294 hasAuthorship W4311154294A5004269034 @default.
• W4311154294 hasAuthorship W4311154294A5011276506 @default.
• W4311154294 hasAuthorship W4311154294A5014405945 @default.
• W4311154294 hasAuthorship W4311154294A5017610862 @default.
• W4311154294 hasAuthorship W4311154294A5019276297 @default.
• W4311154294 hasAuthorship W4311154294A5019488402 @default.
• W4311154294 hasAuthorship W4311154294A5044996527 @default.
• W4311154294 hasAuthorship W4311154294A5045649013 @default.
• W4311154294 hasAuthorship W4311154294A5048163457 @default.
• W4311154294 hasAuthorship W4311154294A5052837574 @default.
• W4311154294 hasAuthorship W4311154294A5061811239 @default.
• W4311154294 hasAuthorship W4311154294A5067804516 @default.
• W4311154294 hasAuthorship W4311154294A5069453818 @default.
• W4311154294 hasAuthorship W4311154294A5077262809 @default.
• W4311154294 hasAuthorship W4311154294A5083622539 @default.
• W4311154294 hasAuthorship W4311154294A5086055038 @default.
• W4311154294 hasAuthorship W4311154294A5090216840 @default.
• W4311154294 hasBestOaLocation W43111542941 @default.
• W4311154294 hasConcept C104317684 @default.
• W4311154294 hasConcept C111566952 @default.
• W4311154294 hasConcept C126322002 @default.
• W4311154294 hasConcept C146291010 @default.
• W4311154294 hasConcept C1491633281 @default.
• W4311154294 hasConcept C150903083 @default.
• W4311154294 hasConcept C207001950 @default.

• next